Advanced health biotechnologies in Thailand: redefining policy directions. Román Pérez Velasco1*, Usa Chaikledkaew2,3, Chaw Yin Myint2 , Roongnapa Khampang2 , Sripen Tantivess2 and Yot Teerawattananon2* Abstract Background: Thailand faces a significant burden in terms of treating and managi

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context? Wantanee Kulpenga, b, , , , Pattara Leelahavaronga, , Waranya Rattanavipaponga, , Vorasith Sornsrivichaib, , Henry C. Baggettc, , Aronrag Meeyaia, d, , , Warunee Punpaniche, ,

Balancing the right to know and the privacy of the patent system: a case study of oncology medicines in Thailand. Inthira Yamabhai; Richard D. Smith Abstract: This study aims to illustrate the processes to determine medicine patent status in developing countries by using oncology medicine in T

A cost–utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand. Adun Mohara1, Román Pérez Velasco1, Naiyana Praditsitthikorn1,2, Yingyos Avihingsanon3 and Yot Teerawattananon1 1Health Intervention and Technology Assessment Program (HITAP),

ROONGNAPA KHAMPANG1,2, SAWITRI ASSANANGKORNCHAI1 & YOT TEERAWATTANANON2 1Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, HatYai, Songkhla, Thailand, and 2Health Intervention and Technology Assessment Program, Department of Health, Ministry of Public Health, Nonthaburi, Tha

Aronrag Meeyai1,2, Naiyana Praditsitthikorn1,3, Surachai Kotirum1, Wantanee Kulpeng1,Weerasak Putthasri4, Ben S. Cooper5,6*, Yot Teerawattananon1 1 Health Intervention and Technology Assessment Program, Nonthaburi, Thailand, 2 Department of Epidemiology, Faculty of Public Health, Mahidol University

Roongnapa Khampang1,2, Sawitri Assanangkornchai2, Linda B Cottler3. 1Epidemiology Unit, Faculty of Medicine, Prince of Songkhla University, Hatyai, Thailand, 2Health Intervention and Technology Assessment Programme, Department of Health, Ministry of Public Health, Nonthaburi, Thailand, 3College

Phanthipha Wongwai a, Pritaporn Kingkaew b, Somkiat Asawaphureekorn a, Tharatip Kolatat c aDepartment of Ophthalmology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40000, Thailand bHealth Intervention and Technology Assessment Program (HITAP), Nonthaburi 11000, Thailand cDepartment of Pa

Thanthima Suwanthawornkul1, Thunyarat Anothaisintawee2*, Abhasnee Sobhonslidsuk3, Ammarin Thakkinstian4, Yot Teerawattananon1 1 Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand, 2 Department of Family Medicine, Faculty of Medicine, Ramathibodi

CATHERINE PITTa,* ANNA VASSALLa, YOT TEERAWATTANANONb, ULLA K. GRIFFITHSa, LORNA GUINNESSa, AMIAN WALKERc, NICOLA FOSTERd and KARA HANSONa a Department of Global Health & Development, London School of Hygiene & Tropical Medicine, London, UK b Health Intervention and Technology Assess